BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11399831)

  • 1. Reducing the residual risk of transfusion-transmitted viruses: mini-pool or single-donation NAT?
    Roth WK; Seifried E
    Transfusion; 2001 Jun; 41(6):845-7. PubMed ID: 11399831
    [No Abstract]   [Full Text] [Related]  

  • 2. Kill and cure. The hope and reality of virus inactivation.
    Prowse C
    Vox Sang; 1994; 67 Suppl 3():191-6. PubMed ID: 7975491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Viral safety measures of plasma for transfusion and applicability in Spain].
    Pereira A
    Med Clin (Barc); 2007 Oct; 129(12):458-68. PubMed ID: 17953912
    [No Abstract]   [Full Text] [Related]  

  • 4. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma.
    Wagner SJ; Friedman LI; Dodd RY
    Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic screening for blood-borne viruses in transfusion settings.
    Lee HH; Allain JP
    Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a limit to the normality of blood products?
    Degos L
    Hematol J; 2000; 1(5):291. PubMed ID: 11920204
    [No Abstract]   [Full Text] [Related]  

  • 7. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ; van Drimmelen HA; Lelie PN
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of leukodepletion in the control of transfusion-transmitted disease.
    Goldman M; Delage G
    Transfus Med Rev; 1995 Jan; 9(1):9-19. PubMed ID: 7719040
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging viruses and transfusion.
    Allain JP
    Transfus Clin Biol; 2001 Jun; 8(3):220-1. PubMed ID: 11499963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus inactivation of fresh plasma.
    Mohr H
    Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood program in Japan: current status.
    Ikeda H
    Transfus Apher Sci; 2002 Apr; 26(2):129-33. PubMed ID: 12121069
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood supply safety: an NHLBI perspective.
    Glynn SA
    Transfusion; 2008 Aug; 48(8):1541-4. PubMed ID: 18713102
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of virus load in blood donations by screening methods.
    Kühnl P; Seidl S; Böhm BO
    Curr Stud Hematol Blood Transfus; 1989; (56):9-22. PubMed ID: 2642787
    [No Abstract]   [Full Text] [Related]  

  • 14. Monetary blood donation incentives and the risk of transfusion-transmitted infection.
    Eastlund T
    Transfusion; 1998 Sep; 38(9):874-82. PubMed ID: 9738629
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for reducing the exposure to donor blood.
    Murphy M
    Clin Med (Lond); 2005; 5(4):337-40. PubMed ID: 16138487
    [No Abstract]   [Full Text] [Related]  

  • 16. Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.
    Tani Y; Aso H; Matsukura H; Tadokoro K; Tamori A; Nishiguchi S; Yoshizawa H; Shibata H;
    Vox Sang; 2012 May; 102(4):285-93. PubMed ID: 22082342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of the blood supply.
    Sloand EM; Pitt E; Klein HG
    JAMA; 1995 Nov; 274(17):1368-73. PubMed ID: 7563562
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current tactics in reducing hazards of virus infection transmission during blood transfusion].
    Golosova TV
    Gematol Transfuziol; 1992 Mar; 37(3):35-7. PubMed ID: 1516800
    [No Abstract]   [Full Text] [Related]  

  • 20. Inactivation of viruses in blood and plasma products.
    Suomela H
    Transfus Med Rev; 1993 Jan; 7(1):42-57. PubMed ID: 8431658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.